Pharmaceutical corporations by U.S. revenue 2020

In terms of revenue, U.S. company AbbVie was the leading pharmaceutical company in the United States in 2020. The company generated nearly 35 billion dollars from pharmaceutical sales in the U.S. during that year, which is a new record high. A large part of this amount is generated by blockbuster drug Humira.

U.S. market is key for Pfizer

Pharmaceutical firm Pfizer has seen its revenue in the United States decline in recent years, but it still accounted for over 50 percent of the company’s overall revenue in 2020. Pfizer has generated worldwide revenues of approximately 42 billion U.S. dollars in 2020. The majority of its revenue comes from the manufacture and sale of biopharmaceutical products. Prevnar 13 – a vaccine that helps protect against pneumococcal bacteria – was the best-selling product in the company’s range in 2020.

Pfizer’s business segments

In 2019, Pfizer reorganized its operating structure into three business segments: biopharma, Upjohn, and consumer healthcare. The biopharma business, which generates the largest share of the company’s revenue, is comprised of six key therapeutic areas, including vaccines, oncology, and internal medicine. Midway through 2019, Pfizer’s consumer healthcare business was combined with the respective business of GlaxoSmithKline (GSK), and the new joint venture began operating globally as GSK Consumer Healthcare. And in 2020, the Upjohn business spun-off and merged with Mylan to form a new company called Viatris.